Applied Therapeutics, Inc. (APLT)
USD 1.08
(-1.82%)
USD 1.08
(-1.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.99 Million | - | - | - | - | - |
| Cost of Revenue | 53.9 Million | 441 Thousand | 415 Thousand | 380 Thousand | 23 Thousand | - |
| Gross Profit | -43.91 Million | -441 Thousand | -415 Thousand | -380 Thousand | -23 Thousand | - |
| Operating Expenses | 74.17 Million | 82.95 Million | 105.61 Million | 94.46 Million | 45.58 Million | 13.51 Million |
| Selling, General and Administrative Expenses | 20.62 Million | 27.31 Million | 43.04 Million | 32.67 Million | 13.23 Million | 2.04 Million |
| Research and Development Expenses | 53.9 Million | 55.63 Million | 62.57 Million | 61.78 Million | 32.35 Million | 11.47 Million |
| Other Expenses | - | -177 Thousand | -521 Thousand | -54 Thousand | -24 Thousand | -1.14 Million |
| Cost and Expenses | 74.52 Million | 82.95 Million | 105.61 Million | 94.46 Million | 45.58 Million | 13.51 Million |
| Operating Income | -64.53 Million | -82.95 Million | -105.61 Million | -94.46 Million | -45.58 Million | -13.51 Million |
| Interest Expense | - | - | 555 Thousand | 559 Thousand | 93 Thousand | - |
| Income Tax Expense | - | -819 Thousand | -970 Thousand | -939 Thousand | -116 Thousand | 4.86 Million |
| Earnings before Tax | -119.76 Million | -82.5 Million | -105.58 Million | -93.96 Million | -45.51 Million | -16.52 Million |
| Net Income | -119.76 Million | -81.68 Million | -104.61 Million | -93.02 Million | -45.39 Million | -16.52 Million |
| Earnings Per Share Basic | -1.42 | -2.16 | -4.09 | -4.23 | -3.54 | -1.80 |
| Earnings Per Share Diluted | -1.42 | -2.16 | -4.09 | -4.23 | -3.54 | -1.80 |
| Weighted Average Shares Outstanding | 84.24 Million | 37.82 Million | 25.59 Million | 21.96 Million | 12.83 Million | 9.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 84.24 Million | 37.82 Million | 25.59 Million | 21.96 Million | 12.83 Million | 9.16 Million |
| Gross Margin | -4.39 | - | - | - | - | - |
| EBIT Margin | -6.46 | - | - | - | - | - |
| Profit Margin | -11.98 | - | - | - | - | - |
| EBITDA | -64.53 Million | -82.06 Million | -105.16 Million | -94.46 Million | -45.58 Million | -3 Million |
| Earnings Before Tax Margin | -6.46 | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 144 Thousand | 190 Thousand | -667 Thousand | 9.99 Million | - | - |
| Cost of Revenue | 122 Thousand | 119 Thousand | 347 Thousand | 353 Thousand | 118 Thousand | 115 Thousand |
| Gross Profit | 22 Thousand | 71 Thousand | -1.01 Million | 9.64 Million | -118 Thousand | -115 Thousand |
| Operating Expenses | 20.46 Million | 9.25 Million | 20.34 Million | 74.17 Million | 15.49 Million | 17.17 Million |
| Selling, General and Administrative Expenses | 10.45 Million | 9.06 Million | 5.03 Million | - | 4.71 Million | 5.29 Million |
| Research and Development Expenses | 10 Million | 190 Thousand | 15.3 Million | - | 10.78 Million | 11.88 Million |
| Other Expenses | -34 Thousand | -26 Thousand | -61 Thousand | -27 Thousand | 10 Thousand | -5000.00 |
| Cost and Expenses | 20.58 Million | 21.28 Million | 20.34 Million | 74.52 Million | 15.49 Million | 17.17 Million |
| Operating Income | -20.44 Million | -21.09 Million | -21 Million | -64.53 Million | -15.49 Million | -17.17 Million |
| Interest Expense | - | - | 721 Thousand | - | - | - |
| Income Tax Expense | - | -119 Thousand | -11.55 Million | 185.1 Thousand | -118 Thousand | 12.39 Million |
| Earnings before Tax | 2.89 Million | -83.93 Million | -37.67 Million | -119.76 Million | -42.37 Million | -29.57 Million |
| Net Income | 2.89 Million | -83.93 Million | -37.67 Million | -119.76 Million | -42.37 Million | -29.57 Million |
| Earnings Per Share Basic | 0.02 | -0.67 | -0.45 | - | -0.47 | -0.37 |
| Earnings Per Share Diluted | -0.13 | -0.67 | -0.45 | - | -0.47 | -0.37 |
| Weighted Average Shares Outstanding | 143.93 Million | 125.31 Million | 84.24 Million | 84.24 Million | 90.66 Million | 79.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 152.39 Million | 125.31 Million | 84.24 Million | 84.24 Million | 90.66 Million | 79.04 Million |
| Gross Margin | 0.15 | 0.37 | 1.52 | 0.96 | - | - |
| EBIT Margin | -141.10 | -111.02 | 6.06 | - | - | - |
| Profit Margin | 20.12 | -441.78 | 56.49 | -11.98 | - | - |
| EBITDA | -20.31 Million | -21.09 Million | -4.04 Million | - | -15.49 Million | -4.25 Million |
| Earnings Before Tax Margin | -141.94 | -111.02 | 31.50 | -6.46 | - | - |
9525
0757
3086
PROK
KCPSUGIND
SRXXF